Tunicamycin reversibly inhibits the terminal differentiation of teratocarcinoma stem cells to endoderm
- 1 January 1983
- journal article
- research article
- Published by Elsevier in Developmental Biology
- Vol. 95 (1), 115-125
- https://doi.org/10.1016/0012-1606(83)90011-8
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Effects of tunicamycin upon glycoprotein synthesis and development of early mouse embryosDevelopmental Biology, 1980
- Identification of noncollagenous basement membrane glycopolypeptides synthesized by mouse parietal entoderm and an entodermal cell lineDevelopmental Biology, 1980
- High molecular weight extracellular proteins synthesized by endoderm cells derived from mouse teratocarcinoma cells and normal extraembryonic membranesDevelopmental Biology, 1980
- Appearance and distribution of collagens and laminin in the early mouse embryoDevelopmental Biology, 1980
- Teratocarcinoma stem cells have a cell surface carbohydrate-binding component implicated in cell-cell adhesionCell, 1979
- Teratocarcinoma EndodermDifferentiation, 1979
- Cell surface morphology and adhesive properties of normal and virally transformed cells treated with tunicamycin, an inhibitor of protein glycosylationExperimental Cell Research, 1978
- Biochemical Markers of the Progress of Differentiation in Cloned Teratocarcinoma Cell LinesEuropean Journal of Biochemistry, 1977
- Neoplastic differentiation: Characteristics of cell lines derived from a murine teratocarcinomaJournal of Cellular Physiology, 1974
- Increased protease levels in transformed cells: A casein overlay assay for the detection of plasminogen activator productionCell, 1974